Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease.
Study Design
- Тип исследования
- Observational Study
- Размер выборки
- 61
- Популяция
- Patients with inflammatory bowel disease
- Длительность
- 260 weeks
- Вмешательство
- Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. None
- Препарат сравнения
- None
- Первичный исход
- Vitamin and zinc status in IBD patients
- Направление эффекта
- Positive
- Риск систематической ошибки
- Unclear
Abstract
Vitamin deficiencies are common in inflammatory bowel disease. Here we present 5-year follow-up data of 61 patients. No folate or vitamin B12 deficiency was identified throughout the study. A daily multivitamin supplement was sufficient to replete 100% of vitamin A-deficient and vitamin E-deficient patients. A total of 52% of vitamin D-deficient patients corrected, but 15% who had normal vitamin D levels at diagnosis developed deficiency. A total of 63% of zinc-deficient patients normalized their zinc status, but 15% developed zinc deficiency at follow-up despite supplementation.
Кратко
A daily multivitamin supplement was sufficient to replete 100% of vitamin A–deficient and vitamin E-deficient patients and no folate or vitamin B12 deficiency was identified throughout the study.
Used In Evidence Reviews
Similar Papers
Journal of inflammation research · 2014
Vitamin D and inflammatory diseases.
The British journal of nutrition · 2002
The immune system: a target for functional foods?
Gastroenterology · 2017
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
The journal of headache and pain · 2020
Gut-brain Axis and migraine headache: a comprehensive review.
Joint bone spine · 2010
Vitamin D and inflammation.
The Australian and New Zealand journal of psychiatry · 2017